🇺🇸 FDA
Patent

US 9938259

Therapeutic compositions and related methods of use

granted A61PA61P13/08A61P3/04

Quick answer

US patent 9938259 (Therapeutic compositions and related methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P13/08, A61P3/04, A61P3/10, A61P35/00